Defiance ETFs has introduced three new leveraged ETFs focused on individual stocks: Palantir Technologies, Hims & Hers Health, and Robinhood Markets. These funds aim to combine leveraged exposure with revenue strategies.
On August 19, 2025, it was announced that Defiance is a pioneer in innovative exchange-traded products.
The newly launched Leveraged Long + Income ETFs cater to investors interested in gaining amplified positions in these companies. For instance, the Leveraged Long + Income PLTR ETF offers leveraged exposure specifically to Palantir Technologies.
Each ETF is designed to provide approximately 150% to 200% of the daily price performance of the underlying stocks. Plus, they feature an options-based income strategy to help generate consistent cash flow while also providing some protection against market downturns.
Notable Features
- Leveraged exposure: The funds aim to deliver amplified returns for investors.
- Income generation: They utilize options to create revenue streams, offering a buffer against potential losses.
- Accessible structure: Investors can engage without needing a margin account.
Rationale Behind Company Selection
- Palantir Technologies: They’re recognized for their AI-driven data analytics platforms used globally by various sectors.
- Hims & Hers Health: This company is transforming access to telehealth and consumer healthcare solutions.
- Robinhood Markets: They are known for making retail investing more accessible, eliminating many traditional fees.
These ETFs primarily target long-term capital gains while also seeking to generate current revenue through income strategies like credit call spreads. However, it’s worth noting that various risks come with such investments, as actual performance could fall short of expectations due to market fluctuations.
Defiance, established in 2018, continues to be at the cutting edge of ETF innovation, focusing on revenue and leveraged ETFs to provide enhanced investment opportunities.
